Unique ID issued by UMIN | UMIN000003057 |
---|---|
Receipt number | R000003710 |
Scientific Title | A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patients |
Date of disclosure of the study information | 2010/01/19 |
Last modified on | 2012/02/20 14:14:12 |
A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patients
Saga-challenge antiDiabetes
Observantional study for sitaGliptin
(S-DOG)
A study on efficacy and safety of a DPP-IV inhibitor in type 2 diabetes patients
Saga-challenge antiDiabetes
Observantional study for sitaGliptin
(S-DOG)
Japan |
Diabetes
Medicine in general |
Others
NO
To carry out treatment with a DPP-IV inhibitor as part of an intensified treatment regimen for patients with type 2 diabetes whose glycemic control is inadequate in order to examine its efficacy, safety and effects on QOL.
Safety,Efficacy
Confirmatory
Pragmatic
Phase IV
Change and % change in HbA1c at 3 months after study initiation.
- Change and % change in HbA1c (excluding values at 3 months), HOMA-beta, TC, HDL-C, TG and body weight at 3, 6, 9 and 12 months after study initiation
- Change and % change in EQ5D and PSQI scores at 3 and 12 months after study initiation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Aggressive antiglycaemic therapy is to be administered by using sitagliptin
20 | years-old | <= |
Not applicable |
Male and Female
1) Type 2 diabetes patients diagnosed according to the clinical diagnostic criteria of the Japan Diabetes Society
2) Patients aged >=20 years
3) Patients who fully understand the study procedures and have given written informed consent on use of their data for the study
1) Patient with a history of severe ketosis, diabetic coma or pre-coma within the past 6 months
2) Patient with severe infection, a recent history of surgery, and those who are scheduled to undergo surgery soon, or serious external wound
3) Pregnant patients, including one trying to conceive pregnancy during the planned study period, and breast-feeding patients
4) Patients with modest to severe renal impairment (creatinine clearance >=30 mL/min; serum creatinine >=1.5mg/dL in men and >=1.3mg/dL in women)
5) Patients with a history of hypersensitivity to the study agent
6) Patients who are considered not eligible for the study by the attending doctor due to medical reasons
300
1st name | |
Middle name | |
Last name | Koichi Node |
Saga University Faculty of Medicine
Department of Cardiovascular and Renal medicine
5-1-1 Nabeshima, Saga-shi, Saga
0952-34-2364
1st name | |
Middle name | |
Last name | Junichi Oyama |
Saga lifestyle related disease treatment study group
secretariat
Department of Cardiovascular, Saga University Faculty of Medicine, 5-1-1Nabeshima, Saga-shi, Saga
0952-34-2364
Saga lifestyle related disease treatment study group secretariat
Medicine foundation (An application for a research grant has been submitted)
Non profit foundation
Japan
NO
佐賀大学医学部(佐賀県)、池田内科・皮フ科医院(佐賀県)、江口病院(佐賀県)、
佐賀記念病院(佐賀県)、権藤医院(佐賀県)、伊万里市立市民病院(佐賀県)、神埼クリニック(佐賀県)、内藤医院北山診療所(佐賀県)、高橋内科(佐賀県)、貝原医院(佐賀県)、水上医院(佐賀県)、古賀病院(佐賀県)、武田内科医院(佐賀県)、田尻外科胃腸科医院(佐賀県)、夢咲クリニック(佐賀県)、神埼病院(佐賀県)、南医院(佐賀県)、蒲地医院(佐賀県)、脇山内科(佐賀県)、ひらまつふれあいクリニック(佐賀県)、内田クリニック(佐賀県)、佐賀市立富士大和温泉病院(佐賀県)、中尾胃腸科医院(佐賀県)、岩本内科(佐賀県)、中西内科(佐賀県)
2010 | Year | 01 | Month | 19 | Day |
Unpublished
Completed
2009 | Year | 12 | Month | 03 | Day |
2009 | Year | 12 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2010 | Year | 01 | Month | 19 | Day |
2012 | Year | 02 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003710